Searched for
ANIL RAGHAVAN
V D Satheesan govt: Mix of experienced and new facesV.D. Satheesan sworn in as Kerala's new Chief Minister, leading a UDF government with 20 ministers. The cabinet blends experience with 14 n...- Sun Pharma Advanced Research jumps 11%, extends 2-day rally as US court clears Sezaby PRVSun Pharma Advanced Research Company surged for a second straight session after a U.S. court ruled in its favour on the Sezaby Priority Rev...
- SPARC enters pact with UCSF and Tiller Therapeutics for early stage oncology assetSun Pharma Advanced Research Company (SPARC) partners with Tiller Therapeutics. SPARC licenses its rights to a promising cancer treatment. ...
- Citigroup's new big hire is a no nonsense, hard-charging dealmakerViswas Raghavan, a competitive and ambitious dealmaker, has been hired by Citigroup CEO Jane Fraser to lead the struggling Wall Street oper...
- Sun Pharma inks licensing pact with SPARC to commercialise medication in US marketSPARC submitted a new drug application (NDA) to the US Food and Drug Administration (US FDA) for the said product in February 2022.
- SPARC enters licensing pact with Biomodifying for licensing of novel drug targets against cancer“This is an important milestone for SPARC. The licensing of antibodies from Biomodifying will assist us in our endeavour to transition SPAR...
- Dilip Shanghvi resigns as MD of SPARCIt further stated that the board, on the recommendation of Nomination and Remuneration Committee, has appointed Anil Raghavan as chief exec...
- National security advisory board's aim is to spread 'security understanding'It was decided that NSAB members would try to spread wider public understanding of India’s national security challenges, perspectives and p...
- SPARC stock tumbles 6% on spasticity study resultsThe stock dropped 5.82 per cent to end the session at Rs 336.70 on the BSE.
- SPARC and Sun Pharma ink licensing pact for epilepsy drug"As per the agreement, SPARC will license Elepsia XRTM (Levetiracetam Extended Release tablets) to a wholly-owned subsidiary of Sun Pharma ...
- Resul Pookutty turns director-producer, eyes Rs 300 cr fundingThe Oscar-winning sound engineer Resul Pookutty, has ust launched a production house Le Penta Entertainment along with Reliance Entertainme...
- SPARC licenses Xelpros to Sun Pharma for US marketSun Pharma Advanced Research Company (SPARC) has licensed out Xelpros, a preservative-free eye drop, to a subsidiary of Sun Pharma for the ...
- SPARC shares settle with 5 per cent gain; market capitalisation up by Rs 440 croreELEPSIA XR is indicated for adjunctive therapy in the treatment of partial onset seizures in patients of 12 years of age and older with epi...
- Good news for borrowers! EMIs may come down post RBI rate cut, say analysts"We have limited room to provide relief to tax payers. But with RBI rate cut, I see EMIs coming down significantly," said Jayant Sinha.
- SPARC gets USFDA nod for its anti-epileptic drug ELEPSIA XR"Approval of ELEPSIA XRTM as 1,000 mg and 1,500 mg once a day tablets will be very useful for these patients and physicians."
- Indians across world celebrate Independence Day with gustoIndians across the globe donned patriotic colours as they celebrated the country's 67th Independence Day.
- Rise & fall of US Inc’s poster boy: How Rajat Gupta fell from a CEO to an apprenticeAnita Raghavan's new book on Rajat Gupta, tracks one of the biggest cases to rattle Wall Street; The fall of Rajat Gupta
- Create a more stable regulatory environment: QuintilesQuintiles seeks stable regulatory environment and regulatory certainty to ensure growth of the Indian contract research organizations (CRO)...
- Panel to review security practicesThe government has set up a task force to review the existing practices in the national security system and suggest measures to strengthen ...
- FACT seeks inquiry, denies leak from its plantDenying any leak of ammonia gas from its plant near here, Fertilisers and Chemicals Travancore (FACT) Limited on Friday urged Ernakulam dis...
Load More
